Fluocinonide--a new topical corticosteroid. Clinical evaluation.
D000085:Acetates; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000627:therapeutic use*; D004304:Dosage Forms; D004952:Esters; D005069:Evaluation Studies as Topic; D005233:Fatty Alcohols; D005446:Fluocinolone Acetonide / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone; D008010:Lichen Planus / Q000188:drug therapy; D009824:Ointments; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D012871:Skin Diseases / Q000188:drug therapy*; D012995:Solubility; D013997:Time Factors; D014631:Valerates / Q000627:therapeutic use
D000085:Acetates; D000893:Anti-Inflammatory Agents; D004304:Dosage Forms; D004952:Esters; D005233:Fatty Alcohols; D009824:Ointments; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D014631:Valerates; D005446:Fluocinolone Acetonide; D001623:Betamethasone; D006854:Hydrocortisone